Analysis of TyG index and TG/HDL ratio with hyperuricemia in patients with H-type hypertension

Ziqiang Luo1, Jie Yang2, Changyi Wang2

  • 1Shenzhen Nanshan Center for Chronic Disease Control. Guangdong Medical University.

Nutricion Hospitalaria
|November 28, 2025
PubMed

Insights

The TyG index and TG/HDL ratio may predict hyperuricemia in H-type hypertension patients. These metabolic indices show stronger predictive power in females, aiding in early risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Syndrome Research
  • Biomarker Discovery

Background:

  • Hyperuricemia and hypertension frequently coexist, posing a significant public health challenge.
  • Identifying reliable predictive markers for this comorbidity is crucial for effective management.

Purpose of the Study:

  • To investigate the association between hyperuricemia and two metabolic indices: the triglyceride-glucose (TyG) index and the triglyceride/high-density lipoprotein (TG/HDL) cholesterol ratio.
  • To conduct a gender-specific analysis in patients with H-type hypertension.

Main Methods:

  • Analysis of data from 7,051 patients in a stroke risk screening program (2017-2018, 2021-2023).
  • Utilized logistic regression and restricted cubic spline modeling to assess risk and dose-response relationships.

Main Results:

  • Elevated TyG index and TG/HDL ratio were linked to increased hyperuricemia risk, particularly in females.
  • Observed nonlinear and linear dose-response relationships for TyG index with hyperuricemia in males and females, respectively.
  • TG/HDL ratio demonstrated a nonlinear association with hyperuricemia in both genders. No correlation with homocysteine levels was found.

Conclusions:

  • The TyG index and TG/HDL ratio show potential as predictive biomarkers for hyperuricemia in H-type hypertension.
  • These indices may be particularly valuable for risk prediction in female patients.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
443
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
708
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
536
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
676
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296